Business Context and Reporting Date
GE HealthCare Technologies Inc. filed a Form 8-K dated September 22, 2026, under Items 5.02, 7.01, and 9.01. The filing reports a board appointment and related Regulation FD disclosure; it does not report quarterly or annual financial results.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating or financial metrics.
Material Changes
- The Board appointed Pascal Desroches as a director, effective January 4, 2027.
- Effective January 4, 2027, Mr. Desroches will join the Audit Committee and the Talent, Culture, and Compensation Committee.
- Upon joining the Board, he will receive compensation under the Company’s non-employee director compensation program and will enter into an indemnification agreement.
- The Company stated that no arrangement or understanding existed regarding his selection and that no related-party transactions reportable under Item 404(a) of Regulation S-K were identified.
Guidance, Outlook, Risks, and Unusual Items
The filing provides no financial guidance or outlook. The Company furnished a September 22, 2026 press release as Exhibit 99 under Item 7.01. The disclosure is not deemed filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly stated.
Investor Verification Points
- Verify the effective date of Mr. Desroches’s appointment and committee memberships: January 4, 2027.
- Review the Company’s March 19, 2026 proxy statement for the applicable non-employee director compensation program.
- Review the indemnification agreement form filed as Exhibit 10.3 to the Company’s February 4, 2026 Form 10-K.
- Review Exhibit 99 for the Company’s complete announcement and any additional biographical information.
- Confirm that this filing contains no new financial results or changes to financial guidance.